A patient with a diagnosis of dysfibrinogenemia is likely to exhibit which of the following clinical manifestations due to an abnormality in fibrinogen?

A Increased risk of venous thromboembolism
B Bleeding tendency due to impaired clot formation
C Enhanced fibrinolysis leading to bleeding
D Immune-mediated destruction of platelets
Dysfibrinogenemia is a rare coagulation disorder characterized by the presence of an abnormal fibrinogen molecule that impairs clot formation, leading to a bleeding tendency.
Orphanet Journal of Rare Diseases
Hematology Hematology: Coagulation Disorders Hematology: Coagulation Disorders Hard MEDICAL Confidence: medium